Cargando…

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units

Detalles Bibliográficos
Autores principales:	Doyle, Andrew J., Thomas, Will, Retter, Andrew, Besser, Martin, MacDonald, Stephen, Breen, Karen A., Desborough, Michael J.R., Hunt, Beverley J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pergamon Press 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543947/ https://www.ncbi.nlm.nih.gov/pubmed/33065410 http://dx.doi.org/10.1016/j.thromres.2020.10.007

Ejemplares similares

Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom
por: Desborough, Michael J.R., et al.
Publicado: (2020)

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Managing suspected venous thromboembolism when a pandemic limits diagnostic testing
por: Schaefer, Jordan K., et al.
Publicado: (2020)

Arterial and venous thromboembolic disease in a patient with COVID-19: A case report
por: Brüggemann, Renée, et al.
Publicado: (2020)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2020)

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
por: Overstad, Siri, et al.
Publicado: (2020)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
por: Stessel, Björn, et al.
Publicado: (2021)

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Preventing hospital associated venous thromboembolism
por: Hunt, Beverley J
Publicado: (2019)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data
por: Choi, Sung-Hee, et al.
Publicado: (2022)

Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review
por: Pandor, Abdullah, et al.
Publicado: (2021)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

The risk of a second cancer after hospitalisation for venous thromboembolism
por: Sørensen, H T, et al.
Publicado: (2005)

The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
por: Previtali, Giulia, et al.
Publicado: (2020)

Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
por: Thomas, W., et al.
Publicado: (2020)

VENOUS THROMBOEMBOLISM IN HOSPITALISED COVID PATIENTS: AN UMBRELLA REVIEW
por: Shah, Komal, et al.
Publicado: (2022)

Venous thromboembolism in patients hospitalised with COVID-19 in England
por: Roberts, Lara N., et al.
Publicado: (2022)

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
por: Ageno, Walter, et al.
Publicado: (2018)

Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis
por: Gil-Díaz, Aída, et al.
Publicado: (2022)

Risk of venous thromboembolism in hospitalised cancer patients in England—a cohort study
por: Ratib, Sonia, et al.
Publicado: (2016)

Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients
por: Creeper, Katherine J., et al.
Publicado: (2022)

Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up
por: Salisbury, Richard, et al.
Publicado: (2020)

Venous thromboembolism risk assessment in hospitalised patients: A new proposal
por: Alckmin, Carolina Alves Vono, et al.
Publicado: (2013)

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era
por: Qin, Wei, et al.
Publicado: (2021)

Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study
por: Khalafallah, Alhossain A, et al.
Publicado: (2016)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

N‐Methyl‐3,4‐methylendioxymethamphetamine (MDMA)‐related coagulopathy and rhabdomyolysis: A case series and literature review
por: Doyle, Andrew J., et al.
Publicado: (2020)

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
por: Echevarria, C, et al.
Publicado: (2017)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Speed, Victoria, et al.
Publicado: (2021)

Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review
por: Pandor, Abdullah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fb76vq8f5lhfsvecffm40u37o0